<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Олейник, Б.А.</author>
     <author>Плечев, В.В.</author>
     <author>Стародубов, В.И.</author>
     <author>Евдаков, В.А.</author>
     <author>Ижбульдин, Р.И.</author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title>ТЕРАПЕВТИЧЕСКИЙ АНГИОГЕНЕЗ КАК ПЕРСПЕКТИВНОЕ НАПРАВЛЕНИЕ ПОТЕНЦИРОВАНИЯ АНГИОГЕННОГО ДЕЙСТВИЯ АОРТОКОРОНАРНОГО ШУНТИРОВАНИЯ</title>
   </titles>
   <dates>
    <year>2023</year>
    <pub-dates>
     <date>2023-06-19</date>
    </pub-dates>
   </dates>
   <doi>10.17802/2306-1278-2023-12-1-118-128</doi>
   <abstract>Coronary artery bypass grafting is the preferred treatment modality for multivessel&#13;
coronary artery disease. However, the clinical efficacy of the procedure decreases&#13;
over time due to the progression of atherosclerosis in the bypass grafts and native&#13;
coronary arteries. In this regard, it is of great scientific and practical interest to disclose the mechanisms affecting the development of the microvasculature during&#13;
myocardial surgical revascularization, as well as the search for pharmacological&#13;
substances capable of stimulating the process of angiogenesis during these&#13;
surgeries to improve short and long-term outcomes. The article presents a review&#13;
of experimental and clinical studies on the effect of coronary artery bypass surgery&#13;
on angiogenesis and highlights the place of pyrimidine derivatives in therapeutic&#13;
angiogenesis in coronary artery disease.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/2776</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/2952</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
